Nev. Admin. Code § 441A.482 - Carbapenem-resistant Enterobacteriaceae

1. The health authority shall, within the limits of available resources, investigate each report of a case having carbapenem-resistant Enterobacteriaceae, as determined in accordance with "Carbapenemase Producing Carbapenem-Resistant Enterobacteriaceae (CP-CRE) 2018 Case Definition," adopted by reference in NAC 441A.200, to:

(a) Confirm the diagnosis;

(b) Determine the extent of any outbreak;

(c) Identify, categorize and evaluate contacts; and

(d) Evaluate the efficacy of any precautions concerning contacts, disease-specific precautions or other precautions for the control of the infection that are in effect.

2. If a case having carbapenem-resistant Enterobacteriaceae is in a medical facility, the medical facility shall:

(a) Take measures to contain the infection in accordance with Facility Guidance for Control of Carbapenem-resistant Enterobacteriaceae (CRE) and Interim Guidance for a Public Health Response to Contain Novel or Targeted Multidrug-resistant Organisms (MRDOs), as adopted by reference in NAC 441A.200;

(b) If the facility wishes to transfer the case to another medical facility, notify the medical facility to which the case will be transferred of the infection and provide instruction to the case concerning the risk, transmission, prevention and control of the infection in accordance with 2007 Guideline for Isolation Precautions: Preventing Transmission of Infectious Agents in Healthcare Settings, as adopted by reference in NAC 441A.200; and

(c) If the medical facility discharges the case, provide instructions to the case concerning the risk, transmission, prevention and control of the infection in accordance with 2007 Guideline for Isolation Precautions: Preventing Transmission of Infectious Agents in Healthcare Settings, as adopted by reference in NAC 441A.200.

3. A medical facility shall provide education to employees on the risk, transmission, prevention and control of carbapenem-resistant Enterobacteriaceae in accordance with 2007 Guideline for Isolation Precautions: Preventing Transmission of Infectious Agents in Healthcare Settings, as adopted by reference in NAC 441A.200.

Notes

Nev. Admin. Code § 441A.482

Added to NAC by Bd. of Health by R187-18A, eff. 6/26/2019; A by R148-22A, eff. 7/26/2023

NRS 439.200, 441A.120